Skip to main content
Erschienen in: Forensic Toxicology 1/2011

01.01.2011 | Short Communication

Possible involvement of Cyp3a enzymes in the metabolism of tetrahydrocannabinols by mouse brain microsomes

verfasst von: Kazuhito Watanabe, Mai Fujinami, Satoshi Yamaori, Ikuo Yamamoto

Erschienen in: Forensic Toxicology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Δ8-Tetrahydrocannabinol (THC) and Δ9-THC were mainly oxidized on the pentyl side chain at the 4′-position by mouse brain microsomes. 5′-Hydroxy-THCs were also formed as minor metabolites. However, 11-hydroxy metabolites of THCs, which are major metabolites of the cannabinoids produced by mouse hepatic microsomes, were not detectable as the metabolites formed by mouse brain microsomes. Cytochrome P450 (CYP) enzymes involved in the brain microsomal metabolism of Δ8-THC and Δ9-THC were identified by using CYP-selective inhibitors. The 4′- and 5′-hydroxylations of THCs were strongly inhibited by ketoconazole and troleandomycin, the known inhibitors of CYP3A enzymes, but not by other isozyme-selective inhibitors, such as 7,8-benzoflavone (CYP1A), quinidine (CYP2D), and sulfaphenazole (CYP2C). These results indicate that Cyp3a enzymes are responsible at least in part for the metabolism of Δ8-THC and Δ9-THC by mouse brain microsomes. Our present results using mouse brain seem to support the idea that the mode of THC metabolism by CYP enzymes in human brain is different from that in human liver.
Literatur
1.
Zurück zum Zitat Goto Y, Araki T, Fuchigami T, Arizono K (2010) Analysis of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in urine by LC–MS–MS after stir-bar sortive extraction and liquid desorption. Forensic Toxicol 28:38–42CrossRef Goto Y, Araki T, Fuchigami T, Arizono K (2010) Analysis of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in urine by LC–MS–MS after stir-bar sortive extraction and liquid desorption. Forensic Toxicol 28:38–42CrossRef
2.
Zurück zum Zitat Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2009) Identificatioon of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol 27:61–66CrossRef Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2009) Identificatioon of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol 27:61–66CrossRef
3.
Zurück zum Zitat Harvey DJ (1984) Chemistry, metabolism, and pharmacokinetics of the cannabinoids. In: Nahas GG (ed) Marijuana in science and medicine. Raven Press, New York, pp 37–107 Harvey DJ (1984) Chemistry, metabolism, and pharmacokinetics of the cannabinoids. In: Nahas GG (ed) Marijuana in science and medicine. Raven Press, New York, pp 37–107
4.
Zurück zum Zitat Yamamoto I, Watanabe K, Narimatsu S, Yoshimura H (1995) Recent advances in the metabolism of cannabinoids. Int J Biochem Cell Biol 27:741–746CrossRefPubMed Yamamoto I, Watanabe K, Narimatsu S, Yoshimura H (1995) Recent advances in the metabolism of cannabinoids. Int J Biochem Cell Biol 27:741–746CrossRefPubMed
5.
Zurück zum Zitat Watanabe K, Narimatsu S, Yamamoto I, Yoshimura H (1991) Oxygenation mechanism in conversion of aldehyde to carboxylic acid catalyzed by a cytochome P-450 isozyme. J Biol Chem 266:2709–2711PubMed Watanabe K, Narimatsu S, Yamamoto I, Yoshimura H (1991) Oxygenation mechanism in conversion of aldehyde to carboxylic acid catalyzed by a cytochome P-450 isozyme. J Biol Chem 266:2709–2711PubMed
6.
Zurück zum Zitat Watanabe K, Narimatsu S, Matsunaga T, Yamamoto I, Yoshimura H (1993) A cytochrome P450 isozyme having aldehyde oxygenase activity plays a major role in metabolizing cannabinoids by mouse hepatic microsomes. Biochem Pharmacol 46:405–411PubMed Watanabe K, Narimatsu S, Matsunaga T, Yamamoto I, Yoshimura H (1993) A cytochrome P450 isozyme having aldehyde oxygenase activity plays a major role in metabolizing cannabinoids by mouse hepatic microsomes. Biochem Pharmacol 46:405–411PubMed
7.
Zurück zum Zitat Bornheim LM, Correia MA (1991) Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome IIC subfamily. Mol Pharmacol 40:228–234PubMed Bornheim LM, Correia MA (1991) Purification and characterization of the major hepatic cannabinoid hydroxylase in the mouse: a possible member of the cytochrome IIC subfamily. Mol Pharmacol 40:228–234PubMed
8.
Zurück zum Zitat Razdan RK (1986) Structure–activity relationships in cannabinoids. Pharm Rev 38:75–149PubMed Razdan RK (1986) Structure–activity relationships in cannabinoids. Pharm Rev 38:75–149PubMed
9.
Zurück zum Zitat Yamamoto I, Watanabe K, Matsunaga T, Kimura T, Funahashi T, Yoshimura H (2003) Pharmacology and toxicology of marihuana—on the metabolic activation of cannabinoids and its mechanism. J Toxicol Toxin Rev 22:577–589 Yamamoto I, Watanabe K, Matsunaga T, Kimura T, Funahashi T, Yoshimura H (2003) Pharmacology and toxicology of marihuana—on the metabolic activation of cannabinoids and its mechanism. J Toxicol Toxin Rev 22:577–589
10.
Zurück zum Zitat Watanabe K, Tanaka T, Yamamoto I, Yoshimura H (1988) Brain microsomal oxidation of Δ8- and Δ9-tetrahydrocannabinol. Biochem Biophys Res Commun 157:75–80CrossRefPubMed Watanabe K, Tanaka T, Yamamoto I, Yoshimura H (1988) Brain microsomal oxidation of Δ8- and Δ9-tetrahydrocannabinol. Biochem Biophys Res Commun 157:75–80CrossRefPubMed
11.
Zurück zum Zitat Aramaki H, Tomiyasu N, Yoshimura H, Tsukamoto H (1968) Forensic chemical study on marihuana. I. A detection method of the principal constituents by thin-layer and gas chromatographies. Chem Pharm Bull 16:822–826PubMed Aramaki H, Tomiyasu N, Yoshimura H, Tsukamoto H (1968) Forensic chemical study on marihuana. I. A detection method of the principal constituents by thin-layer and gas chromatographies. Chem Pharm Bull 16:822–826PubMed
12.
Zurück zum Zitat Gaoni Y, Mechoulam R (1966) Hashish-VII, the isomerization of cannabidiol to tetrahydrocannabinols. Tetrahedron 22:1481–1488CrossRef Gaoni Y, Mechoulam R (1966) Hashish-VII, the isomerization of cannabidiol to tetrahydrocannabinols. Tetrahedron 22:1481–1488CrossRef
13.
Zurück zum Zitat Ohlsson A, Agurell S, Leander K, Dahmen J, Edery H, Porath G, Levy S, Mechoulam R (1979) Synthesis and psychotropic activity of side chain hydroxylated Δ6-tetrahydrocannabinol metabolite. Acta Pharm Suec 16:21–33PubMed Ohlsson A, Agurell S, Leander K, Dahmen J, Edery H, Porath G, Levy S, Mechoulam R (1979) Synthesis and psychotropic activity of side chain hydroxylated Δ6-tetrahydrocannabinol metabolite. Acta Pharm Suec 16:21–33PubMed
14.
Zurück zum Zitat Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I (2006) 8-Hydroxycannabinol: a new metabolite of cannabinol formed by human hepatic microsomes. Forensic Toxicol 24:80–82CrossRef Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I (2006) 8-Hydroxycannabinol: a new metabolite of cannabinol formed by human hepatic microsomes. Forensic Toxicol 24:80–82CrossRef
15.
Zurück zum Zitat Watanabe K, Itokawa Y, Yamaori S, Funahashi T, Kimura T, Kaji T, Yamamoto I (2007) Conversion of cannabidiol to Δ9-tetrahydrocannabinol and related cannabinoids in artificial gastric juice, and their pharmacological effects in mice. Forensic Toxicol 25:16–21CrossRef Watanabe K, Itokawa Y, Yamaori S, Funahashi T, Kimura T, Kaji T, Yamamoto I (2007) Conversion of cannabidiol to Δ9-tetrahydrocannabinol and related cannabinoids in artificial gastric juice, and their pharmacological effects in mice. Forensic Toxicol 25:16–21CrossRef
16.
Zurück zum Zitat Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I (2007) Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci 80:1415–1419CrossRefPubMed Watanabe K, Yamaori S, Funahashi T, Kimura T, Yamamoto I (2007) Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes. Life Sci 80:1415–1419CrossRefPubMed
17.
Zurück zum Zitat Harvey DJ (1981) The mass spectra of the trimethylsilyl derivatives of the hydroxy and acid metabolites of Δ1- and Δ6-tetrahydrocannabinol. Biomed Mass Spectrom 8:579–588CrossRefPubMed Harvey DJ (1981) The mass spectra of the trimethylsilyl derivatives of the hydroxy and acid metabolites of Δ1- and Δ6-tetrahydrocannabinol. Biomed Mass Spectrom 8:579–588CrossRefPubMed
18.
Zurück zum Zitat Ravindranath V (1998) Metabolism of xenobiotics in the central nervous system: implications and challenges. Biochem Pharmacol 56:547–551CrossRefPubMed Ravindranath V (1998) Metabolism of xenobiotics in the central nervous system: implications and challenges. Biochem Pharmacol 56:547–551CrossRefPubMed
19.
Zurück zum Zitat Newton DJ, Wang RW, Lu AYH (1995) Cytochrome P450 inhibitors, evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab Dispos 23:154–158PubMed Newton DJ, Wang RW, Lu AYH (1995) Cytochrome P450 inhibitors, evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes. Drug Metab Dispos 23:154–158PubMed
20.
Zurück zum Zitat Ono S, Hatanaka T, Hotta H, Satoh T, Gonzalez FJ, Tsutsumi M (1996) Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 26:681–693CrossRefPubMed Ono S, Hatanaka T, Hotta H, Satoh T, Gonzalez FJ, Tsutsumi M (1996) Specificity of substrate and inhibitor probes for cytochrome P450s: evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes. Xenobiotica 26:681–693CrossRefPubMed
21.
Zurück zum Zitat Rosenbrock H, Hagnmeyer CE, Ditter M, Knoth R, Volk B (2001) Identification, induction and localization of cytochrome P450s of the 3A-subfamily in mouse brain. Neurotox Res 4:339–349CrossRef Rosenbrock H, Hagnmeyer CE, Ditter M, Knoth R, Volk B (2001) Identification, induction and localization of cytochrome P450s of the 3A-subfamily in mouse brain. Neurotox Res 4:339–349CrossRef
22.
Zurück zum Zitat Hagenmeyer CE, Rosenbrock H, Ditter M, Knoth R, Volk B (2003) Predominatly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. Neuroscience 117:521–529CrossRef Hagenmeyer CE, Rosenbrock H, Ditter M, Knoth R, Volk B (2003) Predominatly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain. Neuroscience 117:521–529CrossRef
23.
Zurück zum Zitat Yamamoto I, Tanaka T, Watanabe K, Narimatsu S, Yoshimura H (1986) Pharmacological activity of side chain hydroxylated metabolites of Δ9-tetrahydrocannabinol in mice. Res Commun Subst Abuse 7:19–27 Yamamoto I, Tanaka T, Watanabe K, Narimatsu S, Yoshimura H (1986) Pharmacological activity of side chain hydroxylated metabolites of Δ9-tetrahydrocannabinol in mice. Res Commun Subst Abuse 7:19–27
24.
Zurück zum Zitat Watanabe K, Tanabe F, Tanaka T, Yamamoto I, Yoshimura H (1990) Pharmacological activity of Δ8-tetrahydrocannabinol derivatives oxidized at the 4-position in mice. Res Commun Subst Abuse 11:39–47 Watanabe K, Tanabe F, Tanaka T, Yamamoto I, Yoshimura H (1990) Pharmacological activity of Δ8-tetrahydrocannabinol derivatives oxidized at the 4-position in mice. Res Commun Subst Abuse 11:39–47
Metadaten
Titel
Possible involvement of Cyp3a enzymes in the metabolism of tetrahydrocannabinols by mouse brain microsomes
verfasst von
Kazuhito Watanabe
Mai Fujinami
Satoshi Yamaori
Ikuo Yamamoto
Publikationsdatum
01.01.2011
Verlag
Springer Japan
Erschienen in
Forensic Toxicology / Ausgabe 1/2011
Print ISSN: 1860-8965
Elektronische ISSN: 1860-8973
DOI
https://doi.org/10.1007/s11419-010-0103-0

Weitere Artikel der Ausgabe 1/2011

Forensic Toxicology 1/2011 Zur Ausgabe

Neu im Fachgebiet Rechtsmedizin

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …